Literature DB >> 11361992

Hepatobiliary and pancreatic infections in AIDS: Part II.

A P Keaveny1, M S Karasik.   

Abstract

In the first part of our review, we discussed the general evaluation and clinical presentation of the various hepatic infections occurring in patients with AIDS. In addition, we focused on specific hepatic parenchymal infections. In this article, we will discuss the major clinical syndromes arising from opportunistic infections affecting the gallbladder (acalculous cholecystitis), biliary tree (AIDS-cholangiopathy), and pancreas (pancreatitis). Acalculous cholecystitis can develop in patients with AIDS who have not experienced the severe precipitating physiologic stresses normally required in patients without AIDS. The most common presentation is with right upper quadrant (RUQ) pain and tenderness. The diagnosis is a clinical one since there is no standard test, other than surgery. Cholecystectomy is the treatment of choice. The most common AIDS-associated infective complication of the biliary tree is AIDS-cholangiopathy. This is best viewed as a form of secondary sclerosing cholangitis resulting from a variety of opportunistic infections within the biliary tree. Affected persons present with RUQ pain and have marked elevations in the canalicular enzymes, alkaline phosphatase, and gamma-glutamyl transferase. Morphologic abnormalities are identified by endoscopic retrograde cholangiopancreatography. These include stricturing, dilatation, and beading of the biliary tract. Endoscopic sphincterotomy of the papilla of Vater may provide symptomatic relief for patients with papillary stenosis. Opportunistic infections within the pancreas gland have been documented in both pre- and postmortem studies. However, the true incidence of pancreatitis related to infections is unknown. The presentation is similar to that of pancreatitis from other causes. A computerized tomogram of the abdomen is the investigation of choice. Tissue aspiration or biopsy of the pancreas is required to demonstrate the presence of an opportunistic infection. The management is usually supportive, as it is rare that a specific infection is identified and treated.

Entities:  

Mesh:

Year:  1998        PMID: 11361992     DOI: 10.1089/apc.1998.12.451

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  5 in total

Review 1.  Liver disease in the HIV-infected individual.

Authors:  Jennifer C Price; Chloe L Thio
Journal:  Clin Gastroenterol Hepatol       Date:  2010-09-17       Impact factor: 11.382

2.  Long-term Outcomes Following Kidney and Liver Transplant in Recipients With HIV.

Authors:  Arya Zarinsefat; Arushi Gulati; Amy Shui; Hillary Braun; Rodney Rogers; Ryutaro Hirose; Nancy Ascher; Peter Stock
Journal:  JAMA Surg       Date:  2022-03-01       Impact factor: 16.681

Review 3.  Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis.

Authors:  Nieun Seo; So Yeon Kim; Seung Soo Lee; Jae Ho Byun; Jin Hee Kim; Hyoung Jung Kim; Moon-Gyu Lee
Journal:  Korean J Radiol       Date:  2016-01-06       Impact factor: 3.500

Review 4.  Epidemiology, determinants, and management of AIDS cholangiopathy: A review.

Authors:  Maliha Naseer; Francis E Dailey; Alhareth Al Juboori; Sami Samiullah; Veysel Tahan
Journal:  World J Gastroenterol       Date:  2018-02-21       Impact factor: 5.742

5.  Non-infectious cholecystopathy secondary to high-dose IL-2 cancer immunotherapy.

Authors:  Kevin Kuppler; Daniel Jeong; Jung W Choi
Journal:  Acta Radiol Open       Date:  2015-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.